Concepedia
9
Publications
380
Citations
H-Index
2014
Active since
Affiliations
Xeris Pharmaceuticals (United States)(Current)
Harvard University
Joslin Diabetes Center
Oregon Health & Science University
Interface (United States)
Brett Newswanger is an author at Xeris Pharmaceuticals (United States).
Publications per year
2014–2019
Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes
Michael R. Rickels, Stephanie N. DuBose, Elena Toschi et al. · Diabetes Care · 2018 · 75 citations · Full text
Development of a Highly Stable, Nonaqueous Glucagon Formulation for Delivery via Infusion Pump Systems
Brett Newswanger, Steve Ammons, Neelima V. Phadnis et al. · Journal of Diabetes Science and Technology · 2014 · 49 citations · Full text
Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation
Virginia Valentine, Brett Newswanger, Steve Prestrelski et al. · Diabetes Technology & Therapeutics · 2019 · 48 citations · Full text
Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes
Morey W. Haymond, Stephanie N. DuBose, Michael R. Rickels et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 42 citations · Full text
A Randomized, Placebo-Controlled Double-Blind Trial of a Closed-Loop Glucagon System for Postbariatric Hypoglycemia
Christopher M. Mulla, Stamatina Zavitsanou, Alejandro José Laguna Sanz et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 41 citations · Full text
Rows per page
1–5 of 9